Data / Form D filings / RetroSense Therapeutics, LLC
RetroSense Therapeutics, LLC: Form D filings
RetroSense Therapeutics, LLC, a biotechnology company in Ann Arbor, MI, filed 3 Form D notices with the SEC between 2011 and 2015. The latest, on October 13, 2015, reports $4.6 million sold of a $5 million offering to 22 investors.
Find out what RetroSense Therapeutics, LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 330 E. LIBERTY STREET, Ann Arbor, MI, 48104
- Phone
- (734) 369-9333
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1520439
The full lists. Form D filings in Michigan: 506 rows, $25.30, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 13, 2015 | Amendment | $4,999,999 | $4,562,255 | $437,744 | 22 | Aug 19, 2015 | sec.gov |
| Aug 31, 2015 | New notice | $4,999,999 | $2,325,249 | $2,674,750 | 21 | Aug 19, 2015 | sec.gov |
| Oct 7, 2011 | New notice | Indefinite | $75,000 | Indefinite | 2 | May 9, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Terry Cross | Director | |
| Cam Gallagher | Director | |
| Sean Ainsworth | Executive Officer, Director | |
| George Lasezkay | Director | |
| Kenneth Kousky | Director |
Other biotechnology companies in Michigan that filed recently
- Dvant Pharma, Inc. $1.2 million · Oct 13, 2026
- iReprogram, Inc offering · Aug 13, 2026
Every Form D from the week of Oct 12, 2015 · All recent filings in Michigan · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what RetroSense Therapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.